NORTHERN TRUST CORP - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 81 filers reported holding SPERO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$107,546
-16.4%
88,881
+0.2%
0.00%
Q2 2023$128,680
+2.9%
88,745
+2.9%
0.00%
Q1 2023$125,071
+3.9%
86,256
+24.0%
0.00%
Q4 2022$120,380
-14.0%
69,584
-0.5%
0.00%
Q3 2022$140,000
+169.2%
69,963
-0.0%
0.00%
Q2 2022$52,000
-97.5%
69,968
-70.7%
0.00%
Q1 2022$2,074,000
-48.8%
238,452
-5.8%
0.00%
-100.0%
Q4 2021$4,054,000
-14.6%
253,200
-1.8%
0.00%0.0%
Q3 2021$4,748,000
+30.4%
257,939
-1.1%
0.00%0.0%
Q2 2021$3,642,000
+3.3%
260,886
+8.9%
0.00%0.0%
Q1 2021$3,527,000
-31.6%
239,578
-9.9%
0.00%0.0%
Q4 2020$5,157,000
+118.9%
265,973
+26.0%
0.00%0.0%
Q3 2020$2,356,000
-17.0%
211,077
+0.6%
0.00%0.0%
Q2 2020$2,840,000
+115.2%
209,917
+28.6%
0.00%
Q1 2020$1,320,000
+1.0%
163,274
+20.1%
0.00%
Q4 2019$1,307,000
+2.7%
135,997
+13.3%
0.00%
Q3 2019$1,273,000
+18.0%
120,084
+28.1%
0.00%
Q2 2019$1,079,000
-4.6%
93,750
+6.1%
0.00%
Q1 2019$1,131,000
+90.1%
88,334
-8.8%
0.00%
Q4 2018$595,000
-40.9%
96,833
+1.1%
0.00%
Q3 2018$1,007,000
+3.0%
95,795
+43.7%
0.00%
Q2 2018$978,000
+3.5%
66,650
+0.4%
0.00%
Q1 2018$945,000
+23.5%
66,359
+1.9%
0.00%
Q4 2017$765,00065,1250.00%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 3,932,209$76,246,00015.85%
Atlas Venture Associates XI, LLC 1,376,968$26,700,0004.23%
Atlas Venture Associates IX, LLC 1,376,968$26,700,0004.23%
BVF INC/IL 2,243,278$43,497,0001.71%
AWM Investment Company, Inc. 372,755$7,228,0000.92%
Alphabet Inc. 889,979$17,257,0000.83%
Rock Springs Capital Management LP 1,235,000$23,947,0000.51%
Novo Holdings A/S 576,702$11,182,0000.48%
Artal Group S.A. 500,000$9,695,0000.21%
Granahan Investment Management 420,320$8,150,0000.18%
View complete list of SPERO THERAPEUTICS INC shareholders